{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:18:52Z","timestamp":1776431932393,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10549-026-07916-6","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:38:45Z","timestamp":1770266325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic accuracy of tumor bed biopsy for predicting pathological complete response in breast cancer patients achieving clinical complete response after neoadjuvant chemotherapy: a meta-analysis"],"prefix":"10.1007","volume":"215","author":[{"given":"Garvit","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bharath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivank","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goonj","family":"Johri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-8676","authenticated-orcid":false,"given":"Dhananjaya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"7916_CR1","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","volume":"25","author":"BL Murphy","year":"2018","unstructured":"Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC (2018) Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes. Ann Surg Oncol 25:2241\u20132248. https:\/\/doi.org\/10.1245\/s10434-018-6531-5","journal-title":"Ann Surg Oncol"},{"key":"7916_CR2","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1200\/JCO.2014.55.2836","volume":"32","author":"A Berruti","year":"2014","unstructured":"Berruti A, Amoroso V, Gallo F, Bertaglia V, Simoncini E, Pedersini R et al (2014) Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. J Clin Oncol 32:3883\u20133891. https:\/\/doi.org\/10.1200\/JCO.2014.55.2836","journal-title":"J Clin Oncol"},{"key":"7916_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.breast.2018.04.018","volume":"40","author":"H Li","year":"2018","unstructured":"Li H, Yao L, Jin P et al (2018) MRI and PET\/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Breast 40:106\u2013115","journal-title":"Breast"},{"key":"7916_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1245\/s10434-015-4918-0","volume":"23","author":"B Schaefgen","year":"2016","unstructured":"Schaefgen B, Mati M, Sinn HP et al (2016) Can routine imaging after neoadjuvant chemotherapy in breast cancer predict pathologic complete response? Ann Surg Oncol 23:789\u2013795","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"7916_CR5","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/bjc.2015.381","volume":"113","author":"J Heil","year":"2015","unstructured":"Heil J, K\u00fcmmel S, Schaefgen B, Paepke S, Thomssen C, Rauch G, Ataseven B, Gro\u00dfe R, Dreesmann V, K\u00fchn T, Loibl S, Blohmer JU, von Minckwitz G (2015) Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. Br J Cancer 113(11):1565\u20131570. https:\/\/doi.org\/10.1038\/bjc.2015.381","journal-title":"Br J Cancer"},{"issue":"1","key":"7916_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annonc.2019.10.012","volume":"31","author":"J Heil","year":"2020","unstructured":"Heil J, Kuerer HM, Pfob A, Rauch G, Sinn HP, Golatta M, Liefers GJ, Vrancken Peeters MJ (2020) Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol 31(1):61\u201371. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.012","journal-title":"Ann Oncol"},{"key":"7916_CR7","doi-asserted-by":"publisher","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, and the PRISMA-DTA Group, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA, Hyde CJ, Korevaar DA, Leeflang MMG, Macaskill P, Reitsma JB, Rodin R, Rutjes AWS, Salameh JP et al (2018) Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy studies: the PRISMA-DTA statement. JAMA 319(4):388\u2013396. https:\/\/doi.org\/10.1001\/jama.2017.19163","DOI":"10.1001\/jama.2017.19163"},{"issue":"8","key":"7916_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536","journal-title":"Ann Intern Med"},{"issue":"4","key":"7916_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","volume":"20","author":"JBS Haldane","year":"1956","unstructured":"Haldane JBS (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20(4):309\u2013311. https:\/\/doi.org\/10.1111\/j.1469-1809.1955.tb01285.x","journal-title":"Ann Hum Genet"},{"issue":"3","key":"7916_CR10","doi-asserted-by":"publisher","first-page":"s461","DOI":"10.1093\/biomet\/43.3-4.461","volume":"43","author":"FJ Anscombe","year":"1956","unstructured":"Anscombe FJ (1956) On estimating binomial response relations. Biometrika 43(3):s461\u2013s464","journal-title":"Biometrika"},{"key":"7916_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1186\/s12885-021-08796-3","volume":"21","author":"X Zheng","year":"2021","unstructured":"Zheng X, Amos CI, Frost HR (2021) Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction. BMC Cancer 21:1053. https:\/\/doi.org\/10.1186\/s12885-021-08796-3","journal-title":"BMC Cancer"},{"issue":"7","key":"7916_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamasurg.2025.1072","volume":"160","author":"M Basik","year":"2025","unstructured":"Basik M, Cecchini RS, De Los Santos JF, Umphrey HR, Julian TB, Mamounas EP, White JR, Lucas PC, Balanoff CR, Tan AR, Weber JJ, Edmonson DA, Brown-Glaberman UA, Diego EJ, Teshome M, Matsen CB, Seaward SA, Wapnir IL, Wagner JL, Tjoe JA et al (2025) Breast tumor-bed biopsy for pathological complete response prediction: the NRG-BR005 nonrandomized clinical trial. JAMA Surg 160(7):723\u2013731. https:\/\/doi.org\/10.1001\/jamasurg.2025.1072","journal-title":"JAMA Surg"},{"issue":"1","key":"7916_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-020-05678-3","volume":"182","author":"HB Lee","year":"2020","unstructured":"Lee HB, Han W, Kim SY, Cho N, Kim KE, Park JH, Ju YW, Lee ES, Lim SJ, Kim JH, Ryu HS, Lee DW, Kim M, Kim TY, Lee KH, Shin SU, Lee SH, Chang JM, Moon HG, Im SA et al (2020) Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial. Breast Cancer Res Treat 182(1):97\u2013105. https:\/\/doi.org\/10.1007\/s10549-020-05678-3","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"7916_CR14","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1245\/s10434-020-09273-0","volume":"28","author":"AA van Loevezijn","year":"2021","unstructured":"van Loevezijn AA, van der Noordaa MEM, van Werkhoven ED, Loo CE, Winter-Warnars GAO, Wiersma T, van de Vijver KK, Groen EJ, Blanken-Peeters CFJM, Zonneveld BJGL, Sonke GS, van Duijnhoven FH, Vrancken Peeters MTFD (2021) Minimally invasive complete response assessment of the breast after neoadjuvant systemic therapy for early breast cancer (MICRA trial): interim analysis of a multicenter observational cohort study. Ann Surg Oncol 28(6):3243\u20133253. https:\/\/doi.org\/10.1245\/s10434-020-09273-0","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7916_CR15","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1245\/s10434-021-10847-9","volume":"29","author":"V Koelbel","year":"2022","unstructured":"Koelbel V, Pfob A, Schaefgen B, Sinn P, Feisst M, Golatta M, Gomez C, Stieber A, Bach P, Rauch G, Heil J (2022) Vacuum-assisted breast biopsy after neoadjuvant systemic treatment for reliable exclusion of residual cancer in breast cancer patients. Ann Surg Oncol 29(2):1076\u20131084. https:\/\/doi.org\/10.1245\/s10434-021-10847-9","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"7916_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.4103","volume":"155","author":"MK Tasoulis","year":"2020","unstructured":"Tasoulis MK, Lee HB, Yang W, Pope R, Krishnamurthy S, Kim SY, Cho N, Teoh V, Rauch GM, Smith BD, Valero V, Mohammed K, Han W, MacNeill F, Kuerer HM (2020) Accuracy of post-neoadjuvant chemotherapy image-guided breast biopsy to predict residual cancer. JAMA Surg 155(12):e204103. https:\/\/doi.org\/10.1001\/jamasurg.2020.4103","journal-title":"JAMA Surg"},{"issue":"1","key":"7916_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.34045","volume":"4","author":"EJ Sutton","year":"2021","unstructured":"Sutton EJ, Braunstein LZ, El-Tamer MB, Brogi E, Hughes M, Bryce Y, Gluskin JS, Powell S, Woosley A, Tadros A, Sevilimedu V, Martinez DF, Toni L, Smelianskaia O, Nyman CG, Razavi P, Norton L, Fung MM, Sedorovich JD, Sacchini V et al (2021) Accuracy of magnetic resonance imaging-guided biopsy to verify breast cancer pathologic complete response after neoadjuvant chemotherapy: a nonrandomized controlled trial. JAMA Netw Open 4(1):e2034045. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.34045","journal-title":"JAMA Netw Open"},{"issue":"4","key":"7916_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/life15040604","volume":"15","author":"B Kilic","year":"2025","unstructured":"Kilic B, Bademler S, Ilhan B, Kizildag Yirgin I, Yilmaz R, Bayram A, Karanlik H (2025) Is it possible to accurately evaluate the tumor bed after neoadjuvant chemotherapy using a 14G tru-cut biopsy? Life 15(4):604. https:\/\/doi.org\/10.3390\/life15040604","journal-title":"Life"},{"key":"7916_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.suronc.2020.10.002","volume":"35","author":"K Narui","year":"2020","unstructured":"Narui K, Ishikawa T, Oba MS, Hasegawa Y, Kaise H, Kawate T, Yamada A, Yamada K, Suzuki Y, Niikura N, Kohno N, Kimoto T, Sugae S, Kosaka Y, Miyashita M, Okamura T, Shimizu D, Tanino H, Tanabe M, Morita S et al (2020) Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsy. Surg Oncol 35:447\u2013452. https:\/\/doi.org\/10.1016\/j.suronc.2020.10.002","journal-title":"Surg Oncol"},{"issue":"7","key":"7916_CR20","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1245\/s10434-018-6481-y","volume":"25","author":"GM Rauch","year":"2018","unstructured":"Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, Arribas E, Sun J, Leung JWT, Krishnamurthy S, Yang WT (2018) Biopsy feasibility trial for breast cancer pathologic complete response detection after neoadjuvant chemotherapy: imaging assessment and correlation endpoints. Ann Surg Oncol 25(7):1953\u20131960. https:\/\/doi.org\/10.1245\/s10434-018-6481-y","journal-title":"Ann Surg Oncol"},{"key":"7916_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejca.2016.09.034","volume":"69","author":"J Heil","year":"2016","unstructured":"Heil J, Schaefgen B, Sinn P, Richter H, Harcos A, Gomez C, Stieber A, Hennigs A, Rauch G, Schuetz F, Sohn C, Schneeweiss A, Golatta M (2016) Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy? Eur J Cancer 69:142\u2013150. https:\/\/doi.org\/10.1016\/j.ejca.2016.09.034","journal-title":"Eur J Cancer"},{"issue":"3","key":"7916_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/SLA.0000000000004246","volume":"275","author":"J Heil","year":"2022","unstructured":"Heil J, Pfob A, Sinn HP, Rauch G, Bach P, Thomas B, Schaefgen B, Kuemmel S, Reimer T, Hahn M, Thill M, Blohmer JU, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Ditsch N et al (2022) Diagnosing pathologic complete response in the breast after neoadjuvant systemic treatment of breast cancer patients by minimal invasive biopsy: oral presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, program number GS5-03. Ann Surg 275(3):576\u2013581. https:\/\/doi.org\/10.1097\/SLA.0000000000004246","journal-title":"Ann Surg"},{"key":"7916_CR23","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00014","volume":"9","author":"N Hariharan","year":"2023","unstructured":"Hariharan N, Rao TS, Rajappa S, Naidu CCK, Raju KVVN, Koppula V, Sannapareddy K, Sudhir R, Kodandapani S, Fonseca D, Murthy S (2023) Accuracy of tumor bed biopsy for predicting pathologic complete response after chemotherapy among women with breast cancer: complete responders in the breast study. JCO Glob Oncol 9:e2300014. https:\/\/doi.org\/10.1200\/GO.23.00014","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"7916_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/bjs\/znac391","volume":"110","author":"EMC Rossi","year":"2023","unstructured":"Rossi EMC, Invento A, Pesapane F, Pagan E, Bagnardi V, Fusco N, Venetis K, Dominelli V, Trentin C, Cassano E, Gilardi L, Mazza M, Lazzeroni M, De Lorenzi F, Caldarella P, De Scalzi A, Girardi A, Sangalli C, Alberti L, Sacchini V et al (2023) Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study. Br J Surg 110(2):217\u2013224. https:\/\/doi.org\/10.1093\/bjs\/znac391","journal-title":"Br J Surg"},{"key":"7916_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fonc.2020.00933","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Zhou Y, Mao F, Lin Y, Zhang X, Shen S, Sun Q (2020) The diagnostic performance of minimally invasive biopsy in predicting breast pathological complete response after neoadjuvant systemic therapy in breast cancer: a meta-analysis. Front Oncol 10:933. https:\/\/doi.org\/10.3389\/fonc.2020.00933","journal-title":"Front Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07916-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:28:52Z","timestamp":1770802132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07916-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7916"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07916-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"75"}}